Abstract
Selective internal radiation therapy (SIRT) is a well-tolerated treatment for hepatocellular carcinoma (HCC) that has been investigated extensively in patients with HCC in Barcelona Clinic Liver Cancer (BCLC) stage B. The present analysis aimed to evaluate the budgetary implications of using SIRT versus conventional transarterial chemoembolization (cTACE) in treating patients with BCLC B HCC in England.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
